|

Psilocybin therapy Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • University Medical Center Groningen1
  • Psyence Australia Pty Ltd1

Indications

  • Atypical Parkinson Disease1
  • ALS (Amyotrophic Lateral Sclerosis)1
  • MS (Multiple Sclerosis)1
  • Major Depressive Disorder (MDD)1
  • Cancer Pancreas1

Other2 trials

Psilocybin Therapy for Psychological Distress in Palliative Patients
Phase 2
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.